EdgeMarketInstruments › GRDX

GRDX — GridAI Technologies Corp.

US Healthcare Pharma & biotech equity mkt cap 24.9M
3.57 -4.83% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 1.90 · high 6.80

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2024-05-17.

Performance

1 day-4.83%
1 week-14.41%
1 month+6.54%
3 months-22.58%
6 months+38.33%
Year to date-30.56%
1 year+73.25%

Technicals

RSI 1463.4
vs 50-day avg-8.56%
vs 200-day avg+6.66%
Volatility 1y135.8%
Max drawdown 1y-64.39%
Avg volume 30d100.6K
Daily bars held567
History from2024-05-17

Measured signals that fired on GRDX

datesignal measured base rate
2026-08-14Short volume far above its own normal
short
-0.76% over 21 days · t = -2.79 · n = 5,897
statistically distinguishable from its control group
2026-03-26Short volume far above its own normal
short
-0.76% over 21 days · t = -2.79 · n = 5,897
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-06-30Sawyer Jason David
Chief Executive Officer
Grant or award250.0K0.000
2026-03-31Sawyer Jason David
Chief Executive Officer
Grant or award250.0K0.000
2026-01-01Syage Jack
Director
Grant or award40.0K0.000
2026-01-01BORKOWSKI EDWARD
Director
Grant or award40.0K0.000
2026-01-01Pursglove Geordan Garrett
Director
Grant or award40.0K0.000
2026-01-01Uppal Manpreet
Director
Grant or award40.0K0.000
2025-12-22Sawyer Jason David
Chief Executive Officer
Grant or award40.0K0.000
2025-12-22Skowron Anna
Interim CFO
Grant or award65.0K0.000
2025-01-06Romano Sarah
Chief Financial Officer
Open-market sale7270.64465
2024-10-09Romano Sarah
Chief Financial Officer
Open-market sale4760.45214

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
RENAISSANCE TECHNOLOGIES LLC371.3K183.8K
Federation des caisses Desjardins du Quebec96.6K47.8K
GEODE CAPITAL MANAGEMENT, LLC67.2K33.3K
STATE STREET CORP47.4K23.4K
VANGUARD CAPITAL MANAGEMENT LLC37.0K18.3K
VANGUARD FIDUCIARY TRUST CO33.0K16.3K
JANE STREET GROUP, LLC25.6K12.7K
HARBOUR INVESTMENTS, INC.16.1K8.0K
UBS Group AG6.4K3.2K
Tower Research Capital LLC (TRC)2.5K1.3K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
NT 10-Q2026-08-142026-06-30on EDGAR ↗
S-1/A2026-07-31on EDGAR ↗
8-K2026-07-232026-07-17on EDGAR ↗
D2026-07-15on EDGAR ↗
S-1/A2026-07-09on EDGAR ↗
SCHEDULE 13D2026-07-08on EDGAR ↗
8-K/A2026-07-072026-07-01on EDGAR ↗
8-K2026-07-062026-07-01on EDGAR ↗

Short selling

Avg short volume, 90d32.1% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about GRDX

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open GRDX in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →